Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 24 filings·Updated 8 Aug 2026
Showing 10 of 24 filings.
8 Aug 20261 filing
Company UpdateNewspaper Publication

Please find enclosed Newspaper Publication pertaining to unaudited financial results for the quarter ended 30th June 2026

Filed 14:55View Source
7 Aug 20261 filing
ResultFinancial Results

Shricon Industries reports Q1 2026 unaudited standalone results: revenue 83.41 lacs, PAT 7.16 lacs

Standalone interim results

  • Q1 2026 unaudited standalone revenue: 83.41 lacs.
  • Other income: 9.24 lacs; total income: 92.65 lacs.
  • Total expenses: 83.08 lacs; profit before tax: 9.57 lacs.
  • Profit after tax: 7.16 lacs.
  • Basic EPS: 0.58 Rs for Q1 2026.
  • Company operates in a single business segment.
  • Limited Review Report: unmodified opinion.
  • Board approved results; meeting held 07 Aug 2026.
  • Trading window opens 48 hours after results.
  • Investor complaints: none pending as of 30 June 2026.
  • Results available on shricon.in and BSE website.
Filed 14:56View Source
5 Aug 20261 filing
Company UpdateAppointment of Statutory Auditor/s

Appointment of Statutory Auditors of the Company for the term of 5 years from 40th AGM till conclusion of 45th AGM.

Filed 17:26View Source
30 Jul 20261 filing
Board Meeting

Shricon Industries to hold Aug 7, 2026 board meeting for unaudited Q1 FY2026-27 results and Limited Review Report

Meeting Details

  • Board meeting scheduled for Friday, 07 August 2026 at the registered office.

Key Agenda Items

  • Consider and record unaudited standalone financial results for quarter ended 30 June 2026.
  • Consider and record Limited Review Report on unaudited results for quarter ended 30 June 2026.
  • Other routine business and any item(s) with the chairman's permission.

Other Notes

  • Audit Committee and other committees to meet on the same day prior to the board meeting.
  • Trading window closed from 01 July 2026 until 48 hours after the audited results announcement.
Filed 12:12View Source
13 Jul 20261 filing
Company UpdateNewspaper Publication

Please find enclosed copies of Newspaper publication regarding completion of dispatch of Annual report, Notice of AGM through electronic mode and letter to shareholders.

Filed 12:13View Source
9 Jul 20263 filings
Company UpdateGeneral

Shricon to distribute Annual Report 2026 via web links and QR code to unregistered-email members

Annual Report distribution to non-registered-email members

  • Enclosed letter provides web links and QR code to access Annual Report 2026 for non-registered-email members.
Filed 17:15View Source
AGM/EGMAGM

Shricon Industries AGM 2026 to adopt financials, appoint directors by rotation, and approve auditors and RPTs

AGM Details

  • AGM on 04 August 2026 at 4:00 PM IST via VC/OAVM.
  • Book closure from 29 July 2026 to 04 August 2026.
  • Record date/cut-off: 28 July 2026.
  • Remote e-voting window: 01–03 August 2026, ends 5:00 PM.
  • VC/OAVM allows 1000 members on first-come basis.
  • Notice and annual report available on company and BSE websites.
  • NSDL provides e-voting facility.

Ordinary Resolutions

  • Adopt audited financial statements for the year ended 31 March 2026.

Auditors

  • Appoint Birla and Associates as Statutory Auditor to fill casual vacancy.
  • Five-year term from this AGM; remuneration Rs 40,000 for FY 2025-26; future amounts fixed by Board.

Related Party Transactions

  • RPT with Career Point Edutech Limited; up to Rs 15 Cr per annum at arm's length.
  • RPT with Career Point University, Hamirpur; inter-corporate deposits up to Rs 15 Cr each.
  • Special resolution to authorize inter-corporate deposits to CP Capital and Sankalp Capital up to Rs 15 Cr each.

Directors

  • Neelima Maheshwari to be appointed as Director by rotation.
Filed 17:06View Source
OthersReg. 34 (1) Annual Report

Shricon Industries Limited: Annual Report 2025-26 — Key Financials, Governance, and Related Party Updates

Financial highlights

  • Revenue from operations ₹403.39 Lacs in FY26, up from ₹58.83 Lacs.
  • Other income ₹17.24 Lacs, up from ₹6.67 Lacs.
  • Profit after tax ₹147.84 Lacs vs a loss ₹14.83 Lacs prior year.
  • EBITDA ₹223.87 Lacs, indicating strong operating performance.
  • No dividend declared for FY25-26.
  • Equity capital ₹124 Lakh; 12.40 million shares issued.

Capital structure & liquidity

  • Borrowings ₹0.93 Lacs (long-term); related party unsecured loan ₹0.93 Lacs.
  • Current assets ₹338.63 Lacs; current ratio 12.00x; current liabilities ₹28.23 Lacs.
  • Cash and cash equivalents ₹51.51 Lacs.
  • Net debt negligible; no long-term debt beyond the above.

Dividends & reserves

  • No dividend; no reserves transferred.
  • Retained earnings ₹405.36 Lacs; total equity ₹441.88 Lacs.
  • Share capital ₹124 Lakh.

Governance & board changes

  • Board size five; two independent directors.
  • Neelima Maheshwari to retire by rotation; reappointment recommended.
  • Rohira resigned 27-Jun-2025; Chandna appointed 22-Jul-2025.
  • Sheetal Jain appointed Additional Executive Director 20-Jun-2025; five-year term.
  • CFO changes: Girish Suman resigned 03-Jul-2025; Rinku Goyal appointed 22-Jul-2025.

Auditors & compliance

  • Birla & Associates appointed to fill casual vacancy; five-year term 40th-45th AGM.
  • Remuneration ₹40,000 for FY2025-26.
  • Audit report: unqualified; no fraud reported.
  • Secretarial auditor Bharat Rathore & Associates; Internal auditor Kamal Gupta & Co.

Related party transactions

  • Related parties: Career Point Edutech Limited and Career Point University Hamirpur.
  • Maximum RPT value ₹15 Crores per annum; arms’ length basis.
  • 2025-26 RPTs: CP Edutech ₹0.94 Lakh; Career Point University Hamirpur ₹3.88 Lakh.
  • Outstanding balances: Sankalp Capital loan ₹206.21 Lakh.
  • Directors’ interests: Om Prakash Maheshwari and Neelima Maheshwari.
  • Transactions disclosed as related party; board/audit committee approvals obtained.

Business developments & operations

  • Core activities: real estate and ecommerce; no change in business.
  • Drug license obtained 15-Jul-2025 for pharma/healthcare trading.
  • Reported to BSE; no subsidiary or joint ventures.

Internal controls & risk management

  • Internal controls adequate; Kamal Gupta & Co. as internal auditor.
  • TCWG committee formed Feb 2026; board oversight of risks.
  • Risk management policy in place; management reviews mitigations.
  • Going concern appropriately considered in financial reporting.

Communications & ESG disclosures

  • Green initiative: paperless communications; AGM via VC/OAVM; remote e-voting.
  • BRSR report included; not in top 1000 by market cap; CSR not applicable.
  • Sexual harassment policy; maternity benefits compliance.
Filed 16:51View Source
6 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

No dematerialisation/rematerialisation requests received for quarter ended 30 June 2026

Demat/remat status

  • No demat/remat requests received for quarter ended 30 June 2026.
  • No intimation to depositories was required due to absence of requests.
Filed 15:26View Source
4 Jul 20261 filing
Company UpdateNewspaper Publication

Submission of Newspaper cutting of Pre-notice of 40th AGM of the Company.

Filed 19:08View Source
Showing 10 of 24 filings